CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-02 | Evans John M. CEO | Option exercise 10b5-1 | +25,000 | $0.67 | $17K | 1,011,667 |
| 2025-10-02 | Evans John M. CEO | Sale 10b5-1 | −25,000 | $24.63 | $616K | 986,667 |
| 2025-10-02 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 19,336 | ||
| 2025-10-01 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −467 | $24.53 | $11K | 44,045 |
| 2025-10-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −373 | $24.53 | $9K | 116,921 |
| 2025-10-01 | Evans John M. CEO | Option exercise 10b5-1 | +25,000 | $0.67 | $17K | 1,011,667 |
| 2025-10-01 | Evans John M. CEO | Sale 10b5-1 | −25,000 | $24.51 | $613K | 986,667 |
| 2025-10-01 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 44,336 | ||
| 2025-07-30 | FMR LLC 10% owner | Sale | −48,374 | $20.50 | $992K | 2,073,665 |
| 2025-07-03 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −876 | $20.12 | $18K | 64,864 |
| 2025-07-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −374 | $16.94 | $6K | 65,740 |
| 2025-06-04 | Walsh Kathleen E Director | Grant or award · Stock Option (Right to Buy) | +33,662 | 33,662 | ||
| 2025-06-04 | Fishman Mark Director | Grant or award · Stock Option (Right to Buy) | +33,662 | 33,662 | ||
| 2025-06-04 | Shaw Christi Director | Grant or award · Stock Option (Right to Buy) | +33,662 | 33,662 | ||
| 2025-06-04 | MARAGANORE JOHN Director | Grant or award · Stock Option (Right to Buy) | +33,662 | 33,662 | ||
| 2025-06-04 | Guindo Chirfi Director | Grant or award · Stock Option (Right to Buy) | +33,662 | 33,662 | ||
| 2025-06-04 | Ho Carole Director | Grant or award · Stock Option (Right to Buy) | +33,662 | 33,662 | ||
| 2025-06-04 | COOPER GRAHAM K Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +33,662 | 33,662 | ||
| 2025-04-02 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −20,997 | $17.73 | $372K | 65,742 |
| 2025-04-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −5,674 | $18.35 | $104K | 117,294 |
Page 5 of 32 · 630 trades